Loading...
•
Jun 30, 2025
ZimVie Q2 2025 Earnings Report
ZimVie reported its second quarter 2025 financial results, showing a slight decrease in net sales but an improvement in net loss and adjusted EBITDA compared to the previous year.
Key Takeaways
ZimVie reported net sales of $116.7 million for the second quarter of 2025, a slight decrease of 0.1% year-over-year. The company significantly improved its net loss, reducing it to $(3.8) million from $(9.6) million in the prior year, and achieved an adjusted diluted EPS of $0.26. Adjusted EBITDA also saw an increase to $17.5 million, reflecting improved operational efficiency.
Net sales for Q2 2025 were $116.7 million, a marginal decrease of 0.1% compared to Q2 2024.
Net loss from continuing operations improved significantly to $(3.8) million in Q2 2025, from $(9.6) million in Q2 2024.
Adjusted EBITDA from continuing operations increased to $17.5 million, with an adjusted EBITDA margin of 15.0%.
GAAP diluted EPS from continuing operations was $(0.14), while adjusted diluted EPS was $0.26 for the quarter.
Revenue by Geographic Location
Forward Guidance
ZimVie is withdrawing its fiscal 2025 guidance due to a pending acquisition by ARCHIMED, which is expected to close by year-end 2025.
Positive Outlook
- Definitive agreement to be acquired by ARCHIMED for $19.00 in cash per share.
- Transaction expected to close by year-end 2025.
- Upon completion, ZimVie will become a privately held company.
- Shares of ZimVie common stock will no longer be publicly traded on NASDAQ.
- The acquisition provides a clear path forward for the company.
Challenges Ahead
- Withdrawal of fiscal 2025 guidance means no future financial outlook from the company.
- No conference call will be hosted for the second quarter due to the pending transaction.
- Reliance on previous financial guidance is no longer advised.
- Transaction is subject to customary closing conditions, including stockholder and regulatory approvals.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...